Clinical Trial Update: Treatment of Moderate and Severe Cirrhotic Portal Hypertension Due to HBV With Fuzheng Huayu and Entecavir [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating Fuzheng Huayu in combination with Entecavir for treatment of portal hypertension due to hepatitis B virus, status currently …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Portal Hypertension

Drugs mentioned

• ENTECAVIR (ENTECAVIR)
• Fuzheng Huayu

Snippet

Sponsor: ShuGuang Hospital | Conditions: Portal Hypertension | Phase 4 | Status: UNKNOWN